Kings Point Capital Management’s Idexx Laboratories IDXX Stock Holding History

Kings Point Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$27K	Sell	50 -11	-18%	-$5.79K	﹤0.01%	434
2021 Q4	$40K	Hold	61	–	–	﹤0.01%	421
2021 Q3	$38K	Buy	61 +11	+22%	+$7.39K	﹤0.01%	396
2021 Q2	$32K	Hold	50	–	–	﹤0.01%	404
2021 Q1	$24K	Hold	50	–	–	﹤0.01%	430
2020 Q4	$25K	Hold	50	–	–	﹤0.01%	395
2020 Q3	$20K	Hold	50	–	–	﹤0.01%	412
2020 Q2	$17K	Sell	50 -90	-64%	-$26.1K	﹤0.01%	384
2020 Q1	$34K	Sell	140 -50	-26%	-$13K	0.01%	315
2019 Q4	$50K	Hold	190	–	–	0.01%	315
2019 Q3	$52K	Buy	190 +50	+36%	+$13.9K	0.01%	290
2019 Q2	$39K	Hold	140	–	–	0.01%	290
2019 Q1	$31K	Hold	140	–	–	0.01%	278
2018 Q4	$26K	Hold	140	–	–	0.01%	284
2018 Q3	$35K	Hold	140	–	–	0.01%	273
2018 Q2	$31K	Hold	140	–	–	0.01%	278
2018 Q1	$27K	Sell	140 -140	-50%	-$25.8K	0.01%	294
2017 Q4	$44K	Buy	+280	New	+$44.1K	0.01%	243

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Kings Point Capital Management's IDXX Position: Q1 2022 in Review

Kings Point Capital Management reduced its Idexx Laboratories (IDXX) stake by 18% in Q1 2022, selling an estimated $5.79K and leaving 50 shares worth $27K. The position accounts for ﹤0.01% of the portfolio, ranked #434.

Kings Point Capital Management first reported a position in IDXX in Q4 2017 and has held it in 18 quarters since. The position peaked at $52K in Q3 2019. 1,032 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.

Kings Point Capital Management held 50 shares of Idexx Laboratories worth $27K as of Q1 2022.
Kings Point Capital Management sold 11 Idexx Laboratories shares in Q1 2022, an estimated $5.79K.
Idexx Laboratories made up ﹤0.01% of Kings Point Capital Management's portfolio in Q1 2022, its #434 holding.
Kings Point Capital Management first reported a position in Idexx Laboratories in Q4 2017 and has held it in 18 quarters since.
Kings Point Capital Management's Idexx Laboratories position peaked at $52K in Q3 2019.
1,032 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.

Based on Kings Point Capital Management's 13F filing for Q1 2022, filed 13 May 2022.